Abstract
Primary Aldosteronism (PA) is the most common form of secondary AH with an estimated prevalence of approximately 4% in hypertensives treated in primary care services and 10% in patients referenced to tertiary hospitals. In the last decade, considerable advances have been made towards the better understanding of PA genetics. Somatic pathogenic variations in KCNJ5, CACNA1D, ATP1A1 and ATP2B…